CalPrivate Bank

PBAM · OTC

$85.64+$1.88 (+2.24%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $83.76

PBAM analyst rating

BuyConsensus of 2 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy2
Hold0
Underperform0
Sell0

12-month price target · 6 analysts

Average $98.43 (+14.9% upside)

Low: $92.92
Now: $85.64
High: $110.25

Upgrades and downgrades

The latest rating actions, newest first

PBAM analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
DA Davidson	Oct 20, 2026	Maintains	Buy	$105.00 → $107.00	78%
Piper Sandler	Oct 20, 2026	Maintains	Overweight	$96.00 → $101.00	68%
DA Davidson	Aug 24, 2026	Maintains	Buy	$96.00 → $105.00	78%
DA Davidson	Jul 20, 2026	Maintains	Buy	$91.00 → $96.00	78%
Piper Sandler	Jul 20, 2026	Maintains	Overweight	$88.00 → $96.00	68%
DA Davidson	Jul 17, 2026	Maintains	Buy	$91.00	78%
DA Davidson	Apr 20, 2026	Maintains	Buy	$80.00 → $91.00	78%
Piper Sandler	Apr 20, 2026	Maintains	Overweight	$77.00 → $88.00	68%
Piper Sandler	Jan 20, 2026	Maintains	Overweight	$78.00 → $77.00	68%
Piper Sandler	Oct 21, 2025	Maintains	Overweight	$77.00 → $73.00	68%

The case for and against

Updated Oct 21, 2026

Bull case

Private Bancorp is attractive because it is still generating new client relationships while deposits rose 7.1% YTD, or 8% excluding brokered balances, and core deposit costs fell 14bp over the past two quarters, supporting a stronger funding mix. Even with net loan growth in a temporary lull and 2026 shaping up as a modest growth year, the bank is preserving pricing discipline, producing strong loan originations, and posting solid profitability with TCE/TA up 15bp YTD to 10.5% and CET1 up 99bp to 13.6%. Its above-peer return profile, improving capital optionality, and recent Nasdaq uplisting also strengthen the outlook by supporting a premium valuation and creating room for buybacks, a dividend policy change, or M&A.

Bear case

Private Bancorp is facing pressure from weakening fundamentals, as repeated risks around deteriorating asset quality, higher deposit funding costs, and softer loan demand point to margin compression and slower, less profitable growth. Noninterest income also weakened materially, with fee income falling to $1.0M from $1.9M in 1Q and net gain on sale income declining to just $4K from $907K in the prior period, signaling reduced earnings support from core activities. At the same time, noninterest expenses rose to $16.9M from $15.7M in 1Q, reflecting higher professional services and uplisting-related costs that further strain profitability.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.